The First Nasal Glucagon

Baqsimi® is indicated for the treatment of severe hypoglycemia in adult and pediatric patients with diabetes ages 4 years and above.

Baqsimi has been granted pre-approved reimbursement for recurring hypoglycemic events in insulin-treated diabetes.

We have a Practical Guide that covers some key information that will support you initiating your Baqsimi to your patients.

How to use Baqsimi®

Instructional video on how to use the Baqsimi® device


Upcoming Lilly Webinars

click here

2x-hero-group-of-people-working-together-in-front-of-window-19017-0201 smaller.jpg

Educational Videos

click here


Sign up for Updates

click here

For more information and ordering of material & demo devices

PP-GN-NO-0048 06.2021